Not a good buy right now for an impatient buyer: price is extended near/through resistance while near-term pattern-based odds skew to further downside.
The stock is trading above the most recent $10 price target from covering analysts after a downgrade, limiting near-term upside support from Wall Street.
Fundamentals in the latest reported quarter show weakening growth (revenue down sharply YoY and net loss), which makes chasing a technical breakout riskier.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the medium-term trend has been up.
Momentum: MACD histogram +0.128 and expanding indicates upside momentum is still present, but it’s late-stage.
Overbought risk: RSI(6) at ~75.7 signals stretched short-term conditions (prone to pullback rather than a clean continuation).
Levels: Pivot 10.34; price (~11.07 pre-market reference) is around/just above R1 (11.043) with next resistance at R2 (11.477). This is a poor “chase” zone for an impatient entry.
Quant/pattern read: Similar-pattern stats imply elevated downside risk (-2.74% next day, -8.18% next week, -16.4% next month), which conflicts with a fresh buy today.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Very low put/call ratios (OI 0.14; volume 0.09) indicate call-heavy, optimistic positioning (can be bullish, but also contrarian-risk if crowded).
Activity: Today’s option volume is elevated vs the 30-day average (~188%), suggesting heightened near-term speculation.
Volatility: IV (30d) ~41.7 vs historical vol ~33.3; IV percentile ~87 indicates options are relatively expensive—often seen around uncertainty/earnings positioning.
Takeaway: Options flow is bullish-leaning, but with rich IV and crowded calls, the risk/reward for a new long stock entry is less attractive here.
Technical Summary
Sell
4
Buy
9
Positive Catalysts
Technical uptrend backdrop (bullish MA alignment; positive MACD) can support bounces if the stock holds above the ~10.34 pivot.
Upcoming earnings: QDEC 2025 earnings on 2026-02-23 after hours could act as a catalyst if results/FFO surprise positively.
Prior operational positives noted by an analyst: lease amendments increasing participation rents on some farms and improving almond/pistachio pricing (benefits farms with participation components).
Neutral/Negative Catalysts
while short-term RSI is stretched—classic setup for a pullback.
Bottom line: Recent quarter trends point to weakening profitability and shrinking revenue base—not the profile to justify buying aggressively into resistance.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Ratings moved more cautious after Q3—Oppenheimer downgraded to Perform from Outperform (2025-11-13) and kept a $10 price target (stock trading near/above that level at the time).
Alliance Global Partners (2025-11-11): Raised PT to $10 from $9 but maintained Neutral; acknowledged Q3 core FFO/share beat and noted liquidity (~$171.6M) while highlighting high cost of capital and lower cap rates as constraints.
Wall Street pros: FFO beat, improving specialty crop pricing for certain leases, and decent liquidity.
Wall Street cons: Higher cost of capital, tougher acquisition economics, and the stock trading around/above the prevailing $10 target after the downgrade—reducing attractiveness for a fresh buy today.
Wall Street analysts forecast LAND stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LAND is 10 USD with a low forecast of 10 USD and a high forecast of 10 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast LAND stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LAND is 10 USD with a low forecast of 10 USD and a high forecast of 10 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
Current: 11.120
Low
10
Averages
10
High
10
Current: 11.120
Low
10
Averages
10
High
10
Morgan Stanley
Bart Gysens
Equal Weight
maintain
AI Analysis
2025-12-05
Reason
Morgan Stanley
Bart Gysens
Price Target
AI Analysis
2025-12-05
maintain
Equal Weight
Reason
Morgan Stanley analyst Bart Gysens raised the firm's price target on Land Securities to 680 GBp from 630 GBp and keeps an Equal Weight rating on the shares.
JPMorgan
Akash Gupta
Neutral
downgrade
2025-12-04
Reason
JPMorgan
Akash Gupta
Price Target
2025-12-04
downgrade
Neutral
Reason
JPMorgan analyst Akash Gupta lowered the firm's price target on Landis+Gyr to CHF 61 from CHF 63 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LAND
